nodes	percent_of_prediction	percent_of_DWPC	metapath
Brinzolamide—Sinus congestion—Metformin—polycystic ovary syndrome	0.0426	0.0663	CcSEcCtD
Brinzolamide—Upset stomach—Metformin—polycystic ovary syndrome	0.0323	0.0503	CcSEcCtD
Brinzolamide—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.0262	0.0407	CcSEcCtD
Brinzolamide—Chest discomfort—Metformin—polycystic ovary syndrome	0.0239	0.0373	CcSEcCtD
Brinzolamide—Nasal congestion—Metformin—polycystic ovary syndrome	0.0169	0.0263	CcSEcCtD
Brinzolamide—Pain in extremity—Metformin—polycystic ovary syndrome	0.0154	0.0239	CcSEcCtD
Brinzolamide—CA5A—endocrine gland—polycystic ovary syndrome	0.0146	0.0994	CbGeAlD
Brinzolamide—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.0142	0.0221	CcSEcCtD
Brinzolamide—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.014	0.0219	CcSEcCtD
Brinzolamide—Breast disorder—Metformin—polycystic ovary syndrome	0.0139	0.0216	CcSEcCtD
Brinzolamide—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.0138	0.0214	CcSEcCtD
Brinzolamide—Angina pectoris—Metformin—polycystic ovary syndrome	0.013	0.0202	CcSEcCtD
Brinzolamide—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.0127	0.0198	CcSEcCtD
Brinzolamide—CYP3A4—urine—polycystic ovary syndrome	0.0126	0.0858	CbGeAlD
Brinzolamide—Infestation—Metformin—polycystic ovary syndrome	0.0119	0.0184	CcSEcCtD
Brinzolamide—Infestation NOS—Metformin—polycystic ovary syndrome	0.0119	0.0184	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.0112	0.0174	CcSEcCtD
Brinzolamide—Bradycardia—Metformin—polycystic ovary syndrome	0.0108	0.0169	CcSEcCtD
Brinzolamide—Rhinitis—Metformin—polycystic ovary syndrome	0.0107	0.0166	CcSEcCtD
Brinzolamide—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.0106	0.0165	CcSEcCtD
Brinzolamide—Oedema peripheral—Metformin—polycystic ovary syndrome	0.0105	0.0163	CcSEcCtD
Brinzolamide—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.0105	0.0163	CcSEcCtD
Brinzolamide—Eye disorder—Metformin—polycystic ovary syndrome	0.00994	0.0155	CcSEcCtD
Brinzolamide—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00988	0.0154	CcSEcCtD
Brinzolamide—Angiopathy—Metformin—polycystic ovary syndrome	0.00965	0.015	CcSEcCtD
Brinzolamide—Immune system disorder—Metformin—polycystic ovary syndrome	0.00961	0.015	CcSEcCtD
Brinzolamide—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00959	0.0149	CcSEcCtD
Brinzolamide—CA14—adrenal gland—polycystic ovary syndrome	0.00932	0.0635	CbGeAlD
Brinzolamide—Malnutrition—Metformin—polycystic ovary syndrome	0.00926	0.0144	CcSEcCtD
Brinzolamide—Erythema—Metformin—polycystic ovary syndrome	0.00926	0.0144	CcSEcCtD
Brinzolamide—Flatulence—Metformin—polycystic ovary syndrome	0.00913	0.0142	CcSEcCtD
Brinzolamide—Dysgeusia—Metformin—polycystic ovary syndrome	0.00907	0.0141	CcSEcCtD
Brinzolamide—Muscle spasms—Metformin—polycystic ovary syndrome	0.00891	0.0139	CcSEcCtD
Brinzolamide—Vision blurred—Metformin—polycystic ovary syndrome	0.00873	0.0136	CcSEcCtD
Brinzolamide—Tremor—Metformin—polycystic ovary syndrome	0.00868	0.0135	CcSEcCtD
Brinzolamide—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00859	0.0134	CcSEcCtD
Brinzolamide—CA9—endocrine gland—polycystic ovary syndrome	0.00852	0.0581	CbGeAlD
Brinzolamide—Malaise—Metformin—polycystic ovary syndrome	0.00835	0.013	CcSEcCtD
Brinzolamide—Palpitations—Metformin—polycystic ovary syndrome	0.00819	0.0127	CcSEcCtD
Brinzolamide—Hypertension—Metformin—polycystic ovary syndrome	0.008	0.0124	CcSEcCtD
Brinzolamide—Chest pain—Metformin—polycystic ovary syndrome	0.00789	0.0123	CcSEcCtD
Brinzolamide—Myalgia—Metformin—polycystic ovary syndrome	0.00789	0.0123	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00783	0.0122	CcSEcCtD
Brinzolamide—Discomfort—Metformin—polycystic ovary syndrome	0.00779	0.0121	CcSEcCtD
Brinzolamide—Infection—Metformin—polycystic ovary syndrome	0.00751	0.0117	CcSEcCtD
Brinzolamide—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00741	0.0115	CcSEcCtD
Brinzolamide—Skin disorder—Metformin—polycystic ovary syndrome	0.00734	0.0114	CcSEcCtD
Brinzolamide—CA5B—adipose tissue—polycystic ovary syndrome	0.00727	0.0496	CbGeAlD
Brinzolamide—Hypotension—Metformin—polycystic ovary syndrome	0.00706	0.011	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00689	0.0107	CcSEcCtD
Brinzolamide—Paraesthesia—Metformin—polycystic ovary syndrome	0.00679	0.0106	CcSEcCtD
Brinzolamide—Dyspnoea—Metformin—polycystic ovary syndrome	0.00674	0.0105	CcSEcCtD
Brinzolamide—Somnolence—Metformin—polycystic ovary syndrome	0.00672	0.0105	CcSEcCtD
Brinzolamide—Dyspepsia—Metformin—polycystic ovary syndrome	0.00665	0.0104	CcSEcCtD
Brinzolamide—Decreased appetite—Metformin—polycystic ovary syndrome	0.00657	0.0102	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00653	0.0102	CcSEcCtD
Brinzolamide—CA5B—adrenal gland—polycystic ovary syndrome	0.00652	0.0445	CbGeAlD
Brinzolamide—Fatigue—Metformin—polycystic ovary syndrome	0.00652	0.0101	CcSEcCtD
Brinzolamide—CA1—adipose tissue—polycystic ovary syndrome	0.00642	0.0438	CbGeAlD
Brinzolamide—CA2—embryo—polycystic ovary syndrome	0.00631	0.043	CbGeAlD
Brinzolamide—CA12—endocrine gland—polycystic ovary syndrome	0.0063	0.043	CbGeAlD
Brinzolamide—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00623	0.0097	CcSEcCtD
Brinzolamide—CA5B—vagina—polycystic ovary syndrome	0.00604	0.0412	CbGeAlD
Brinzolamide—Urticaria—Metformin—polycystic ovary syndrome	0.00601	0.00935	CcSEcCtD
Brinzolamide—CA5B—endocrine gland—polycystic ovary syndrome	0.00565	0.0385	CbGeAlD
Brinzolamide—Asthenia—Metformin—polycystic ovary syndrome	0.00542	0.00844	CcSEcCtD
Brinzolamide—Pruritus—Metformin—polycystic ovary syndrome	0.00535	0.00832	CcSEcCtD
Brinzolamide—Diarrhoea—Metformin—polycystic ovary syndrome	0.00517	0.00805	CcSEcCtD
Brinzolamide—CA2—adrenal cortex—polycystic ovary syndrome	0.00517	0.0352	CbGeAlD
Brinzolamide—CA4—pituitary gland—polycystic ovary syndrome	0.00504	0.0343	CbGeAlD
Brinzolamide—CA4—adipose tissue—polycystic ovary syndrome	0.00502	0.0342	CbGeAlD
Brinzolamide—Dizziness—Metformin—polycystic ovary syndrome	0.005	0.00778	CcSEcCtD
Brinzolamide—CA1—endocrine gland—polycystic ovary syndrome	0.00499	0.034	CbGeAlD
Brinzolamide—Vomiting—Metformin—polycystic ovary syndrome	0.00481	0.00748	CcSEcCtD
Brinzolamide—Rash—Metformin—polycystic ovary syndrome	0.00477	0.00742	CcSEcCtD
Brinzolamide—Dermatitis—Metformin—polycystic ovary syndrome	0.00476	0.00741	CcSEcCtD
Brinzolamide—Headache—Metformin—polycystic ovary syndrome	0.00474	0.00737	CcSEcCtD
Brinzolamide—CA4—adrenal gland—polycystic ovary syndrome	0.0045	0.0307	CbGeAlD
Brinzolamide—Nausea—Metformin—polycystic ovary syndrome	0.00449	0.00699	CcSEcCtD
Brinzolamide—CA4—female gonad—polycystic ovary syndrome	0.0042	0.0286	CbGeAlD
Brinzolamide—CA2—pituitary gland—polycystic ovary syndrome	0.00418	0.0285	CbGeAlD
Brinzolamide—CA2—adipose tissue—polycystic ovary syndrome	0.00416	0.0284	CbGeAlD
Brinzolamide—CA4—endocrine gland—polycystic ovary syndrome	0.0039	0.0266	CbGeAlD
Brinzolamide—CA2—adrenal gland—polycystic ovary syndrome	0.00373	0.0254	CbGeAlD
Brinzolamide—CA2—female gonad—polycystic ovary syndrome	0.00348	0.0237	CbGeAlD
Brinzolamide—CA2—vagina—polycystic ovary syndrome	0.00346	0.0236	CbGeAlD
Brinzolamide—CA2—endocrine gland—polycystic ovary syndrome	0.00324	0.0221	CbGeAlD
Brinzolamide—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00209	0.0142	CbGeAlD
Brinzolamide—CA12—Metabolism—HSD3B2—polycystic ovary syndrome	0.000462	0.00219	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—RRM2—polycystic ovary syndrome	0.000461	0.00219	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—RRM2—polycystic ovary syndrome	0.000461	0.00219	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—YAP1—polycystic ovary syndrome	0.000456	0.00217	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—AKR1C1—polycystic ovary syndrome	0.000448	0.00212	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—STAR—polycystic ovary syndrome	0.000447	0.00212	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—SULT2A1—polycystic ovary syndrome	0.000445	0.00211	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—SULT2A1—polycystic ovary syndrome	0.000445	0.00211	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—YAP1—polycystic ovary syndrome	0.000445	0.00211	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—YAP1—polycystic ovary syndrome	0.000445	0.00211	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—NAMPT—polycystic ovary syndrome	0.000439	0.00208	CbGpPWpGaD
Brinzolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000436	0.00207	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PNPLA2—polycystic ovary syndrome	0.000435	0.00206	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—HMMR—polycystic ovary syndrome	0.000434	0.00206	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—CYP11A1—polycystic ovary syndrome	0.000433	0.00205	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—RRM2—polycystic ovary syndrome	0.000431	0.00204	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—RRM2—polycystic ovary syndrome	0.000431	0.00204	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—NAMPT—polycystic ovary syndrome	0.000427	0.00203	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—NAMPT—polycystic ovary syndrome	0.000427	0.00203	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—CYP11A1—polycystic ovary syndrome	0.000422	0.002	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—CYP11A1—polycystic ovary syndrome	0.000422	0.002	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—HMMR—polycystic ovary syndrome	0.000416	0.00197	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—YAP1—polycystic ovary syndrome	0.000415	0.00197	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—YAP1—polycystic ovary syndrome	0.000415	0.00197	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—HSD3B1—polycystic ovary syndrome	0.000414	0.00196	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—SULT2A1—polycystic ovary syndrome	0.000412	0.00196	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—SRD5A1—polycystic ovary syndrome	0.000412	0.00196	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—AKR1C3—polycystic ovary syndrome	0.000409	0.00194	CbGpPWpGaD
Brinzolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000405	0.00192	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—CYP17A1—polycystic ovary syndrome	0.000403	0.00191	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—RRM2—polycystic ovary syndrome	0.000399	0.00189	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—NAMPT—polycystic ovary syndrome	0.000399	0.00189	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—NAMPT—polycystic ovary syndrome	0.000399	0.00189	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—AKR1C3—polycystic ovary syndrome	0.000399	0.00189	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—AKR1C3—polycystic ovary syndrome	0.000399	0.00189	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—HMMR—polycystic ovary syndrome	0.000399	0.00189	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000397	0.00188	CbGpPWpGaD
Brinzolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000396	0.00188	CbGpPWpGaD
Brinzolamide—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000394	0.00187	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CYP11A1—polycystic ovary syndrome	0.000394	0.00187	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CYP11A1—polycystic ovary syndrome	0.000394	0.00187	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—STAR—polycystic ovary syndrome	0.000393	0.00187	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—CYP17A1—polycystic ovary syndrome	0.000392	0.00186	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—CYP17A1—polycystic ovary syndrome	0.000392	0.00186	CbGpPWpGaD
Brinzolamide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00039	0.00185	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—YAP1—polycystic ovary syndrome	0.000385	0.00183	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—HSD3B1—polycystic ovary syndrome	0.00038	0.0018	CbGpPWpGaD
Brinzolamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.00038	0.0018	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—LHB—polycystic ovary syndrome	0.000377	0.00179	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—AKR1C3—polycystic ovary syndrome	0.000372	0.00177	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—AKR1C3—polycystic ovary syndrome	0.000372	0.00177	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—NAMPT—polycystic ovary syndrome	0.00037	0.00175	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—HSD3B2—polycystic ovary syndrome	0.000369	0.00175	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CYP17A1—polycystic ovary syndrome	0.000366	0.00174	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CYP17A1—polycystic ovary syndrome	0.000366	0.00174	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CYP11A1—polycystic ovary syndrome	0.000365	0.00173	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—LHB—polycystic ovary syndrome	0.000362	0.00172	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—AKR1C1—polycystic ovary syndrome	0.000357	0.00169	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000353	0.00168	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—HMMR—polycystic ovary syndrome	0.00035	0.00166	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—TH—polycystic ovary syndrome	0.000348	0.00165	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—LHB—polycystic ovary syndrome	0.000347	0.00165	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—AKR1C3—polycystic ovary syndrome	0.000345	0.00164	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000342	0.00162	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—TH—polycystic ovary syndrome	0.00034	0.00161	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—TH—polycystic ovary syndrome	0.00034	0.00161	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CYP17A1—polycystic ovary syndrome	0.000339	0.00161	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—SLC2A4—polycystic ovary syndrome	0.000339	0.00161	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000339	0.00161	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—HSD3B1—polycystic ovary syndrome	0.000334	0.00159	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—SLC2A4—polycystic ovary syndrome	0.00033	0.00157	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—SLC2A4—polycystic ovary syndrome	0.00033	0.00157	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—SULT2A1—polycystic ovary syndrome	0.000329	0.00156	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000328	0.00156	CbGpPWpGaD
Brinzolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000321	0.00152	CbGpPWpGaD
Brinzolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000319	0.00151	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—CYP19A1—polycystic ovary syndrome	0.000319	0.00151	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—RRM2—polycystic ovary syndrome	0.000318	0.00151	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—TH—polycystic ovary syndrome	0.000317	0.0015	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—TH—polycystic ovary syndrome	0.000317	0.0015	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000315	0.00149	CbGpPWpGaD
Brinzolamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000315	0.00149	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—CYP19A1—polycystic ovary syndrome	0.000311	0.00147	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—CYP19A1—polycystic ovary syndrome	0.000311	0.00147	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—SLC2A4—polycystic ovary syndrome	0.000308	0.00146	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—SLC2A4—polycystic ovary syndrome	0.000308	0.00146	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—YAP1—polycystic ovary syndrome	0.000307	0.00146	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—RRM2—polycystic ovary syndrome	0.000305	0.00145	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—LHB—polycystic ovary syndrome	0.000305	0.00145	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000302	0.00143	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—HSD3B2—polycystic ovary syndrome	0.000298	0.00141	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—NAMPT—polycystic ovary syndrome	0.000295	0.0014	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—YAP1—polycystic ovary syndrome	0.000294	0.0014	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—TH—polycystic ovary syndrome	0.000294	0.00139	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—RRM2—polycystic ovary syndrome	0.000293	0.00139	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CYP11A1—polycystic ovary syndrome	0.000291	0.00138	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CYP19A1—polycystic ovary syndrome	0.00029	0.00138	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CYP19A1—polycystic ovary syndrome	0.00029	0.00138	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—AKR1C1—polycystic ovary syndrome	0.000289	0.00137	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—SLC2A4—polycystic ovary syndrome	0.000286	0.00136	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—GNAS—polycystic ovary syndrome	0.000284	0.00135	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—NAMPT—polycystic ovary syndrome	0.000283	0.00134	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—YAP1—polycystic ovary syndrome	0.000282	0.00134	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.00028	0.00133	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000279	0.00132	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—GNAS—polycystic ovary syndrome	0.000277	0.00131	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—GNAS—polycystic ovary syndrome	0.000277	0.00131	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—AKR1C3—polycystic ovary syndrome	0.000275	0.0013	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—VEGFA—polycystic ovary syndrome	0.000271	0.00129	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—NCOR1—polycystic ovary syndrome	0.000271	0.00129	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—NAMPT—polycystic ovary syndrome	0.000271	0.00129	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CYP17A1—polycystic ovary syndrome	0.000271	0.00128	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CYP19A1—polycystic ovary syndrome	0.000269	0.00127	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000268	0.00127	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—SULT2A1—polycystic ovary syndrome	0.000266	0.00126	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—NCOR1—polycystic ovary syndrome	0.000264	0.00125	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—NCOR1—polycystic ovary syndrome	0.000264	0.00125	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000264	0.00125	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000261	0.00124	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000259	0.00123	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—GNAS—polycystic ovary syndrome	0.000259	0.00123	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—GNAS—polycystic ovary syndrome	0.000259	0.00123	CbGpPWpGaD
Brinzolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000259	0.00123	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000258	0.00122	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—RRM2—polycystic ovary syndrome	0.000257	0.00122	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—CYP1A1—polycystic ovary syndrome	0.000257	0.00122	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000253	0.0012	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—CYP1A1—polycystic ovary syndrome	0.00025	0.00119	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—CYP1A1—polycystic ovary syndrome	0.00025	0.00119	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000249	0.00118	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—YAP1—polycystic ovary syndrome	0.000248	0.00118	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—NCOR1—polycystic ovary syndrome	0.000246	0.00117	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—NCOR1—polycystic ovary syndrome	0.000246	0.00117	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—GNAS—polycystic ovary syndrome	0.00024	0.00114	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—MTHFR—polycystic ovary syndrome	0.000239	0.00114	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—NAMPT—polycystic ovary syndrome	0.000238	0.00113	CbGpPWpGaD
Brinzolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000238	0.00113	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP11A1—polycystic ovary syndrome	0.000235	0.00112	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—TH—polycystic ovary syndrome	0.000234	0.00111	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CYP1A1—polycystic ovary syndrome	0.000234	0.00111	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CYP1A1—polycystic ovary syndrome	0.000234	0.00111	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—MTHFR—polycystic ovary syndrome	0.000233	0.00111	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—MTHFR—polycystic ovary syndrome	0.000233	0.00111	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000232	0.0011	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000228	0.00108	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—NCOR1—polycystic ovary syndrome	0.000228	0.00108	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—SLC2A4—polycystic ovary syndrome	0.000228	0.00108	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—TH—polycystic ovary syndrome	0.000225	0.00107	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—AKR1C3—polycystic ovary syndrome	0.000222	0.00105	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP17A1—polycystic ovary syndrome	0.000219	0.00104	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—SLC2A4—polycystic ovary syndrome	0.000218	0.00104	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—MTHFR—polycystic ovary syndrome	0.000218	0.00103	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—MTHFR—polycystic ovary syndrome	0.000218	0.00103	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CYP1A1—polycystic ovary syndrome	0.000216	0.00103	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000216	0.00102	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000215	0.00102	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—TH—polycystic ovary syndrome	0.000215	0.00102	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CYP19A1—polycystic ovary syndrome	0.000214	0.00102	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000212	0.00101	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000209	0.000993	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CYP19A1—polycystic ovary syndrome	0.000205	0.000974	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—MTHFR—polycystic ovary syndrome	0.000202	0.000957	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000197	0.000934	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PPARG—polycystic ovary syndrome	0.000194	0.000921	CbGpPWpGaD
Brinzolamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000193	0.000914	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—POMC—polycystic ovary syndrome	0.000191	0.000909	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GNAS—polycystic ovary syndrome	0.000191	0.000907	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—INS—polycystic ovary syndrome	0.00019	0.000904	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PPARG—polycystic ovary syndrome	0.000189	0.000898	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PPARG—polycystic ovary syndrome	0.000189	0.000898	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—TH—polycystic ovary syndrome	0.000189	0.000898	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—IL6—polycystic ovary syndrome	0.000188	0.00089	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—POMC—polycystic ovary syndrome	0.000187	0.000885	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—POMC—polycystic ovary syndrome	0.000187	0.000885	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—INS—polycystic ovary syndrome	0.000186	0.00088	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—INS—polycystic ovary syndrome	0.000186	0.00088	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—SLC2A4—polycystic ovary syndrome	0.000184	0.000873	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GNAS—polycystic ovary syndrome	0.000183	0.00087	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—NCOR1—polycystic ovary syndrome	0.000182	0.000864	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PPARG—polycystic ovary syndrome	0.000177	0.000838	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PPARG—polycystic ovary syndrome	0.000177	0.000838	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GNAS—polycystic ovary syndrome	0.000176	0.000834	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—NCOR1—polycystic ovary syndrome	0.000175	0.000828	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—POMC—polycystic ovary syndrome	0.000174	0.000827	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—POMC—polycystic ovary syndrome	0.000174	0.000827	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—INS—polycystic ovary syndrome	0.000173	0.000822	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—INS—polycystic ovary syndrome	0.000173	0.000822	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP19A1—polycystic ovary syndrome	0.000173	0.000821	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CYP1A1—polycystic ovary syndrome	0.000173	0.000819	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00017	0.000808	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000168	0.000797	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—NCOR1—polycystic ovary syndrome	0.000167	0.000794	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CYP1A1—polycystic ovary syndrome	0.000166	0.000785	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PPARG—polycystic ovary syndrome	0.000164	0.000776	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—POMC—polycystic ovary syndrome	0.000161	0.000766	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—MTHFR—polycystic ovary syndrome	0.000161	0.000764	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—INS—polycystic ovary syndrome	0.000161	0.000762	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000159	0.000753	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GNAS—polycystic ovary syndrome	0.000154	0.000733	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—MTHFR—polycystic ovary syndrome	0.000154	0.000732	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—MTHFR—polycystic ovary syndrome	0.000148	0.000702	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—NCOR1—polycystic ovary syndrome	0.000147	0.000698	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP1A1—polycystic ovary syndrome	0.000139	0.000662	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000137	0.000652	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000135	0.000643	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PPARG—polycystic ovary syndrome	0.000131	0.000619	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—MTHFR—polycystic ovary syndrome	0.00013	0.000617	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—POMC—polycystic ovary syndrome	0.000129	0.000611	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—INS—polycystic ovary syndrome	0.000128	0.000607	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PPARG—polycystic ovary syndrome	0.000125	0.000594	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—POMC—polycystic ovary syndrome	0.000123	0.000585	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—INS—polycystic ovary syndrome	0.000123	0.000582	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000121	0.000573	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PPARG—polycystic ovary syndrome	0.00012	0.000569	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—POMC—polycystic ovary syndrome	0.000118	0.000561	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—INS—polycystic ovary syndrome	0.000118	0.000558	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.00011	0.000524	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.00011	0.000524	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PPARG—polycystic ovary syndrome	0.000105	0.0005	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—POMC—polycystic ovary syndrome	0.000104	0.000493	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—INS—polycystic ovary syndrome	0.000103	0.000491	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000103	0.000487	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000102	0.000486	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	8.73e-05	0.000414	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	8.73e-05	0.000414	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	7.32e-05	0.000347	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	6.94e-05	0.000329	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	6.62e-05	0.000314	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	5.9e-05	0.00028	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	5.63e-05	0.000267	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	5.13e-05	0.000243	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	5.02e-05	0.000238	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	4.86e-05	0.00023	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	4.47e-05	0.000212	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	4.33e-05	0.000205	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	4.17e-05	0.000198	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	4.01e-05	0.00019	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	3.96e-05	0.000188	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	3.74e-05	0.000177	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	3.68e-05	0.000175	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—TH—polycystic ovary syndrome	3.19e-05	0.000151	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	3.1e-05	0.000147	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	2.91e-05	0.000138	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	2.6e-05	0.000123	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	2.48e-05	0.000118	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	2.35e-05	0.000111	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	2.19e-05	0.000104	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.78e-05	8.42e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.75e-05	8.31e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.74e-05	8.26e-05	CbGpPWpGaD
